Sophia Randolph - 09 Jun 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
09 Jun 2023
Transactions value $
$48,171
Form type
4
Filing time
13 Jun 2023, 16:38:34 UTC
Previous filing
03 Jan 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Options Exercise $7.69K +4.03K +1.49% $1.91 274K 09 Jun 2023 Direct
transaction ALXO Common Stock Options Exercise $10.4K +2.55K +0.93% $4.08 277K 09 Jun 2023 Direct
transaction ALXO Common Stock Options Exercise $30.1K +6.26K +2.26% $4.81 283K 09 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Options Exercise $0 -4.03K -100% $0.00* 0 09 Jun 2023 Common Stock 4.03K $1.91 Direct F1
transaction ALXO Employee Stock Option (right to buy) Options Exercise $0 -2.55K -2.68% $0.00 92.6K 09 Jun 2023 Common Stock 2.55K $4.08 Direct F2
transaction ALXO Employee Stock Option (right to buy) Options Exercise $0 -6.26K -24.69% $0.00 19.1K 09 Jun 2023 Common Stock 6.26K $4.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
F2 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.